Overexpression of the heme oxygenase-1 (HO-1) gene in many solid tumors was believed to be one reason why cancer patients undergoing radiotherapy or chemotherapy failed to respond. The aim of this study was to evaluate whether Inhibitor of HO-1, zinc protoporphyrin IX (Znpp), enhances the radiosensitivity in human nonsmall cell lung cancer (NSCLC) A549 Cells. A549 cells were induced by Znpp and irradiated by X-rays. Then, expression of HO-1 was measured by real-time polymerase chain reaction. Cell survival was evaluated using the MTS assay and the clonogenic survival assay; apoptosis and cell cycle distribution were monitored by flow cytometry. First, overexpression of the HO-1 mRNA was found in treatment with irradiation alone in A549 cells, and expression of the HO-1 mRNA was reduced after combined treatments with 12 μmol/L of Znpp and irradiation. Second, diminished cell viability percentage, decreased cell clonogenic survival fraction, enhanced cell apoptotic index, and increased percentage of cells in the G1 phase were found after combined treatments with 12 μmol/L of Znpp and irradiation compared to either treatment alone (p<0.05). Inhibitor of HO-1, Znpp, can increase the radiosensitivity of human NSCLC A549 cells.
Get full access to this article
View all access options for this article.
References
1.
FangJ, AkaikeT, MaedaH. Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment. Apoptosis, 2004; 9:27.
2.
GoodmanAI, ChoudhuryM, da SilvaJLet al.Overexpression of the heme oxygenase gene in renal cell carcinoma. Proc Soc Exp Biol Med, 1997; 214:54.
3.
MainesMD, AbrahamssonPA. Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution. Urology, 1996; 47:727.
4.
BerberatPO, DambrauskasZ, GulbinasAet al.Inhibition of heme oxygease-l increase responsiveness of pancreatic cancer cells to anticancer treatment. Clin cancer Res, 2005; 11:3790.
5.
TanZe ming, WuYing, ZhangHua liet al.CoCl2-induced chemotherapy resistance in SW480 cells, its mechanism. J Cent South Univ (Med Sci), 2006; 31:345.
YokoyamaS, MitaS, OkabeAet al.Prediction of radiosensitivity in human esophageal squamous cell carcinomas with heme oxygenase-1: a clinicopathological and immunohistochemical study. Oncol Rep, 2001; 8:355.
8.
RyterSW, ChoiAM. Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy. Am J Respir Cell Mol Biol, 2009; 41:251.
9.
DuranteW. Heme oxygenase-1 in growth control and its clinical application to vascular disease. J Cell Physiol, 2003; 195:373.
10.
MorseD, ChoiAM. Heme oxygenase-1: the “emerging molecule” has arrived. Am J Respir Cell Mol Biol, 2002; 27:8.
11.
RyterSW, AlamJ, ChoiAM. Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiol Rev, 2006; 86:583.
12.
DeshaneJ, WrightM, AgarwalA. Heme oxygenase-1 expression in disease states. Acta Biochim Pol, 2005; 52:273.
13.
YinXJ, MaJY, AntoniniJMet al.Roles of reactive oxygen species and heme oxygenase-1 in modulation of alveolar macrophage-mediated pulmonary immune responses to Listeria monocytogenes by diesel exhaust particles. Toxicol Sci, 2004; 82:143.
14.
JungID, LeeJS, LeeCMet al.Induction of indoleamine 2,3-dioxygenase expression via heme oxygenase-1-dependant pathway during murine dendritic cell maturation. Biochem Pharmacol, 2010; 80:491.
15.
FangJ, SawaT, AkaikeTet al.Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. Int J Cancer, 2004; 109:1.
16.
DoiK, AkaikeT, FujiiSet al.Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. Br J Cancer, 1999; 80:1945.
17.
Bao WenHua, Qi ZhenYun, Zhong xiaoLi. HO-1 mRNA expression in lung cancers. Hei Long Jiang Med Pharm, 2006; 29:59.
18.
Gao-JueWu, LinLin, Hong-JieZhanget al.Effect of interference in heme oxygenase on colonic dysfunction of diabetic rats. World Chin J Digestol, 2007; 15:14.
19.
LivakKJ, SchmittgenTD. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-ΔΔCT Method. Methods, 2001; 25:402.
20.
KikuchiA, YamayaM, SuzukiSet al.Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet, 2005; 116:354.
21.
ShibaharaS, SatoM, MullerRMet al.Structural organization of the human heme oxygenase gene and the function of its promoter. Eur J Biochem, 1989; 179:557.
22.
YamadaN, YamayaM, OkinagaSet al.Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet, 2000; 66:187.
23.
JozkowiczA, WasH, DulakJ. Heme oxygenase-1 in tumors: Is it a false friend?Antioxid Redox Signal, 2007; 9:2099.
24.
ZhangJunkai, WangZhongyu, DingDapenget al.Effect of astragulus injection on chemosensitivity of drug-resistant hepatic carcinoma Bel/Fu cell line. Chin J Surg Integr Tradit West Med, 2008; 14:398.
25.
HiraiK, SasahiraT, OhmoriHet al.Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int J Cancer, 2007; 120:500.
26.
PolyakK, WaldmanT, HeTCet al.Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev, 1996; 10:1945.
27.
LoweSW, SchmittEM, SmithSWet al.p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 1993; 362:847.
28.
ClarkeAR, PurdieCA, HarrisonDJet al.Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 1993; 362:849.
29.
MerrittAJ, PottenCS, KempCJet al.The Role of p53 in Spontaneous and Radiation-induced Apoptosis in the Gastrointestinal Tract of Normal and p53-deficient Mice. Cancer Res, 1994; 54:614.
